List of Excipients in API benazepril hydrochloride and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing benazepril hydrochloride and hydrochlorothiazide
Excipients in ANDA-approved (generic) drugs containing benazepril hydrochloride and hydrochlorothiazide
Detailed excipient profiles for benazepril hydrochloride and hydrochlorothiazide
Excipient focus: ANHYDROUS LACTOSE
benazepril hydrochloride and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
benazepril hydrochloride and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | benazepril hydrochloride and hydrochlorothiazide | 52959-595 |
| Physicians Total Care Inc | benazepril hydrochloride and hydrochlorothiazide | 54868-5256 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
benazepril hydrochloride and hydrochlorothiazide drug variants containing CROSPOVIDONE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 27
benazepril hydrochloride and hydrochlorothiazide drug variants containing D&C RED NO. 27
benazepril hydrochloride and hydrochlorothiazide drug variants not containing D&C RED NO. 27
Excipient focus: FD&C BLUE NO. 1
benazepril hydrochloride and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
benazepril hydrochloride and hydrochlorothiazide drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | benazepril hydrochloride and hydrochlorothiazide | 63629-2680 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
benazepril hydrochloride and hydrochlorothiazide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | benazepril hydrochloride and hydrochlorothiazide | 0832-0483 |
| Bryant Ranch Prepack | benazepril hydrochloride and hydrochlorothiazide | 63629-2680 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
benazepril hydrochloride and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | benazepril hydrochloride and hydrochlorothiazide | 0832-0483 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
benazepril hydrochloride and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
benazepril hydrochloride and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| Ranbaxy Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 63304-154 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROGENATED CASTOR OIL
benazepril hydrochloride and hydrochlorothiazide drug variants containing HYDROGENATED CASTOR OIL
benazepril hydrochloride and hydrochlorothiazide drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROXYPROPYL CELLULOSE
benazepril hydrochloride and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | benazepril hydrochloride and hydrochlorothiazide | 60429-403 |
| Apotex Corp | benazepril hydrochloride and hydrochlorothiazide | 60505-0261 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
benazepril hydrochloride and hydrochlorothiazide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| Bryant Ranch Prepack | benazepril hydrochloride and hydrochlorothiazide | 63629-2680 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
benazepril hydrochloride and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
benazepril hydrochloride and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
benazepril hydrochloride and hydrochlorothiazide drug variants containing HYPROMELLOSES
benazepril hydrochloride and hydrochlorothiazide drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
benazepril hydrochloride and hydrochlorothiazide drug variants containing LACTOSE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
benazepril hydrochloride and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
benazepril hydrochloride and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 62559-414 |
| Ranbaxy Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 63304-154 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
benazepril hydrochloride and hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 62559-414 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLOXAMER 188
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLOXAMER 188
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLOXAMER 188
Excipient focus: POLYDEXTROSE
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| ANI Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 62559-414 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 62559-414 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 8000
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOLS
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYSORBATE 80
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
benazepril hydrochloride and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
benazepril hydrochloride and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants containing SILICON DIOXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
benazepril hydrochloride and hydrochlorothiazide drug variants containing STARCH, CORN
benazepril hydrochloride and hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
benazepril hydrochloride and hydrochlorothiazide drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing STEARIC ACID
Excipient focus: TALC
benazepril hydrochloride and hydrochlorothiazide drug variants containing TALC
benazepril hydrochloride and hydrochlorothiazide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
benazepril hydrochloride and hydrochlorothiazide drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 0378-4725 |
| ANI Pharmaceuticals Inc | benazepril hydrochloride and hydrochlorothiazide | 62559-414 |
| >Company | >Ingredient | >NDC |
benazepril hydrochloride and hydrochlorothiazide drug variants not containing TRIACETIN
Excipient focus: ZINC STEARATE
benazepril hydrochloride and hydrochlorothiazide drug variants containing ZINC STEARATE
benazepril hydrochloride and hydrochlorothiazide drug variants not containing ZINC STEARATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
